QT
RLAY icon

Quantamental Technologies’s Relay Therapeutics RLAY Stock Holding History

Quantamental Technologies’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$97.8K Buy
+11,625
New +$125K 0.09% 254

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Quantamental Technologies's RLAY Position: Q3 2023 in Review

Quantamental Technologies opened a new position in Relay Therapeutics (RLAY) in Q3 2023: 11,625 shares worth $97.8K. The stake represents 0.09% of the portfolio and ranks #254 among its holdings.

172 funds tracked by Wall St. Rank hold RLAY as of Q3 2023.

  • Quantamental Technologies held 11,625 shares of Relay Therapeutics worth $97.8K as of Q3 2023.
  • Relay Therapeutics was a new Quantamental Technologies position in Q3 2023.
  • Relay Therapeutics made up 0.09% of Quantamental Technologies's portfolio in Q3 2023, its #254 holding.
  • 172 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2023.

Based on Quantamental Technologies's 13F filing for Q3 2023, filed 14 Nov 2023.